TP53 alterations are frequent in AVPC and SCLC [24,49,71] and mostly include deleterious mutations that extend the protein’s half-life, resulting in nuclear accumulation, detected by IHC [47,49]. Here, TP53 is linked to small cell lung carcinoma.